Diagnosis criteria for hypertension

Reading File
Finding Sources
Searching PubMed

"hypertension" AND "diagnostic criteria"

Searching the Web

hypertension diagnosis criteria 2024 guidelines ACC AHA JNC

Finding Sources
Reading Web Page

hypertension diagnosis criteria blood pressure thresholds classification

Reading File
Reading File
Finding Sources
Reading File
I now have excellent, comprehensive data to answer this question. Let me compile it all.

Diagnosis Criteria for Hypertension

1. ACC/AHA Classification (USA - 2017, reaffirmed 2025)

This is the most widely used classification for adults (≥18 years):
BP CategorySystolic BP (mmHg)Diastolic BP (mmHg)
Normal<120and<80
Elevated120-129and<80
Stage 1 Hypertension130-139or80-89
Stage 2 Hypertension≥140or≥90
  • If systolic and diastolic readings fall in different categories, use the higher classification.
  • Diagnosis requires an average of ≥2 readings on ≥2 separate occasions.
  • Patients on antihypertensive medication are classified as hypertensive regardless of current BP.
- Harrison's Principles of Internal Medicine 22E, Table 288-1; Fuster and Hurst's The Heart 15th Ed, Table 5-1

2. ESC/ESH Classification (Europe - 2023/2024)

The European guidelines retain the traditional ≥140/90 mmHg threshold for diagnosis and use a grade-based system:
CategorySystolic (mmHg)Diastolic (mmHg)
Optimal<120and<80
Normal120-129and/or80-84
High Normal130-139and/or85-89
Grade 1 Hypertension140-159and/or90-99
Grade 2 Hypertension160-179and/or100-109
Grade 3 Hypertension≥180and/or≥110
- Comprehensive Clinical Nephrology 7th Ed, Table 34.3

3. Out-of-Office BP Thresholds for Hypertension Diagnosis

Office BP alone can miss white-coat and masked hypertension. Both ACC/AHA and ESC guidelines now incorporate out-of-office monitoring:
Measurement TypeThreshold for Hypertension
Office/Clinic BP≥140 and/or ≥90 mmHg
24-hour ambulatory (mean)≥130 and/or ≥80 mmHg
Daytime (awake) ambulatory≥135 and/or ≥85 mmHg
Nighttime (asleep) ambulatory≥120 and/or ≥70 mmHg
Home BP monitoring (HBPM)≥135 and/or ≥85 mmHg
- Comprehensive Clinical Nephrology 7th Ed; 2025 AHA/ACC Guideline

4. Hypertension in Children and Adolescents

  • Children 1-12 years: Hypertension = BP at or above the 95th percentile (age-, sex-, and height-specific norms), or SBP ≥130 or DBP ≥80 mmHg
  • Adolescents ≥13 years: Same criteria as adults (≥130/80 for Stage 1, ≥140/90 for Stage 2)
  • Elevated BP in children: ≥90th percentile to <95th percentile, or ≥120/80 to <95th percentile
- Fuster and Hurst's The Heart 15th Ed; Harrison's 22E

5. Special Situations

Hypertension in Pregnancy (ACOG criteria):
  • Hypertension: SBP ≥140 mmHg and/or DBP ≥90 mmHg
  • Severe hypertension (in preeclampsia): SBP ≥160 mmHg or DBP ≥110 mmHg on two occasions ≥4 hours apart
Hypertensive Urgency/Emergency (Stage 2 severe): SBP ≥180 and/or DBP ≥120 mmHg with or without target organ damage

6. Key Diagnostic Points (2025 AHA/ACC Guideline Updates)

The 2025 AHA/ACC Guideline (which replaces the 2017 version) introduced several updates:
  • Home BP monitoring (HBPM) and ambulatory BP monitoring (ABPM) are now central to confirming diagnosis - not just supplementary
  • White-coat hypertension (elevated office BP, normal out-of-office BP) must be excluded before initiating therapy
  • Masked hypertension (normal office BP, elevated out-of-office BP) must be detected to avoid undertreatment
  • Risk stratification now uses the PREVENT calculator for 10- and 30-year total CVD risk, replacing the older Pooled Cohort Equations
  • Primary aldosteronism screening is now recommended for all patients with Stage 2 or resistant hypertension, regardless of potassium level

Summary: Key Threshold Comparison

GuidelineHypertension Threshold
ACC/AHA 2017/2025 (USA)≥130/80 mmHg (Stage 1)
ESC/ESH 2023/2024 (Europe)≥140/90 mmHg (Grade 1)
JNC 7 (older)≥140/90 mmHg
The ACC/AHA threshold of ≥130/80 remains controversial - the European and most international guidelines still use ≥140/90 as the cutoff for defining hypertension, though they classify 130-139/85-89 as "high normal" which warrants close monitoring and lifestyle intervention.

Amlodipine + valsartan

Reading File
Finding Sources
Finding Sources
Searching PubMed

"amlodipine" AND "valsartan" AND "hypertension"

Searching the Web

amlodipine valsartan combination therapy hypertension mechanism clinical evidence

Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive information from multiple authoritative textbooks. Let me compile a thorough answer.

Amlodipine + Valsartan Combination

This is a well-established fixed-dose combination (FDC) marketed as Exforge, pairing a dihydropyridine calcium channel blocker (CCB) with an angiotensin receptor blocker (ARB). The two drugs work through complementary and partially synergistic mechanisms.

Individual Drug Profiles

Amlodipine (CCB - Dihydropyridine)

Mechanism: Blocks L-type voltage-gated calcium channels in vascular smooth muscle, causing peripheral arterial vasodilation. Unlike non-dihydropyridines (verapamil, diltiazem), it has minimal cardiac effects (no significant negative chronotropy/inotropy) and does not slow AV conduction. It binds to both dihydropyridine and non-dihydropyridine receptor sites, producing vasodilation without significant sympathetic nervous system activation.
Pharmacokinetics:
  • Almost complete oral absorption; peak plasma levels at 6-12 hours
  • Half-life: 30-50 hours (uniquely long among CCBs; prolonged further in elderly)
  • No sustained-release formulation needed - once-daily dosing
  • 90% hepatic metabolism, 10% excreted unchanged; no dose adjustment needed in renal impairment
  • Antihypertensive effect may persist up to 5 days after discontinuation
Dosing: 2.5 mg (starting dose, especially elderly) to 10 mg once daily
- Brenner and Rector's The Kidney 2-Vol Set; Lippincott Illustrated Reviews Pharmacology

Valsartan (ARB - Angiotensin II Receptor Blocker)

Mechanism: Selective competitive antagonist of AT₁ (angiotensin II type 1) receptors. Blocks the vasoconstrictive and aldosterone-secreting effects of angiotensin II, resulting in arteriolar dilation, reduced aldosterone release (natriuresis), and decreased preload/afterload.
Key indications beyond hypertension:
  • Heart failure (reduces mortality/morbidity)
  • Post-MI with LV dysfunction (VALIANT trial: non-inferior to captopril for all-cause mortality)
  • Available as sacubitril/valsartan (Entresto) for HFrEF
Dosing: 80-320 mg once daily for hypertension
- Goodman & Gilman's Pharmacological Basis of Therapeutics

Rationale for the Combination

The combination is pharmacologically rational for several reasons:
RationaleExplanation
Complementary mechanismsCCB dilates via calcium blockade; ARB dilates via RAAS blockade - different pathways with additive BP reduction
Edema attenuationCombining an ARB/ACEi with a CCB reduces CCB-associated peripheral edema by up to 38% (ARBs counteract CCB-induced precapillary dilation by also dilating postcapillary venules, reducing transcapillary pressure gradient)
Countering reflex activationCCBs can trigger reflex renin/Ang II release; ARBs block this compensatory rise
Reduced BP variabilityCCBs are among the most effective agents for reducing visit-to-visit BP variability, a predictor of stroke and MI
RAAS blockadeProtects kidneys and heart independently of BP lowering
- Brenner and Rector's The Kidney; Comprehensive Clinical Nephrology 7th Ed

Indications

  • Hypertension not controlled by monotherapy - the primary indication (Exforge)
  • Stage 2 hypertension - combination may be used as initial therapy when BP is >20/10 mmHg above target
  • Hypertension with CKD or diabetes - ARB component provides additional renoprotection
  • Hypertension with LV hypertrophy - ARB component reduces LVH
  • Hypertension + stable angina - amlodipine also reduces anginal episodes

Available Formulations (Exforge)

AmlodipineValsartan
5 mg160 mg
10 mg160 mg
5 mg320 mg
10 mg320 mg
A triple combination with HCTZ (Exforge HCT: amlodipine/valsartan/hydrochlorothiazide) is available for resistant hypertension, with trials showing superior BP control vs. dual therapy.

Adverse Effects

DrugKey Adverse Effects
AmlodipinePeripheral edema (dose-dependent), headache, flushing, palpitations, reflex tachycardia
ValsartanHyperkalemia (especially with CKD), hypotension (first dose), dizziness; rarely angioedema, hepatitis, neutropenia
CombinationEdema reduced vs. amlodipine alone; hypotension risk; avoid in bilateral renal artery stenosis

Contraindications / Precautions

  • Pregnancy - valsartan is teratogenic (Category D/X); discontinue immediately if pregnancy occurs
  • Bilateral renal artery stenosis - ARB can precipitate acute renal failure
  • Hyperkalemia - ARB caution with K+-sparing diuretics, K+ supplements, or renal disease
  • Severe aortic stenosis - CCB-mediated vasodilation may cause hemodynamic compromise
  • Do NOT combine with ACEi or aliskiren - dual RAAS blockade increases adverse renal outcomes without added CV benefit

Clinical Evidence

The VALUE trial compared valsartan- vs. amlodipine-based regimens in high-CV-risk hypertensive patients: amlodipine achieved faster initial BP control, but long-term CV outcomes were similar. The combination capitalizes on both drugs' strengths.
A 2023 network meta-analysis (PMID 37432701) confirmed that single-pill combinations including amlodipine/ARB were among the most effective regimens for BP control in uncontrolled hypertension.
The 2025 AHA/ACC Guideline lists CCB + ARB (or CCB + ACEi) as a preferred combination for most hypertensive patients, particularly those with diabetes, CKD, or high cardiovascular risk.

Create a dosing & monitoring protocol document for amlodipine/valsartan therapy

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Running Command
Running Command
Writing File
Running Command
Running Command
Running Command
Running Command
The document is ready. Download it here:

Amlodipine Valsartan Protocol

Word Document · DOCX


Here's what the document contains across 10 sections:
SectionContent
Cover PageTitle, version, date, source references
1. Drug OverviewMechanism of action table (CCB vs ARB), pharmacokinetics comparison, rationale for combination
2. Indications & ContraindicationsApproved uses; colour-coded contraindications table (pregnancy, bilateral RAS, dual RAAS blockade, etc.)
3. Dosing ProtocolAll 4 Exforge® tablet strengths; standard adult initiation/titration/maximum dose steps; special population table (elderly, CKD, hepatic impairment, pregnancy, breastfeeding, paediatric)
4. BP Targets2025 AHA/ACC vs 2024 ESC targets by patient population
5. Monitoring ProtocolBaseline assessment checklist; follow-up schedule (2 weeks → 6 months → annual); critical lab thresholds with specific action triggers
6. Adverse Effects10 adverse effects with drug attribution, frequency, and management
7. Drug Interactions10 interactions colour-coded by severity (contraindicated / major / moderate)
8. Patient CounsellingAdministration, lifestyle modifications (DASH, sodium, exercise, alcohol, smoking), safety warnings
9. Escalation / Referral8 clinical scenarios with specific actions including hypertensive emergency
10. ReferencesGuideline + textbook sources with PMIDs

Which is best to take this medicine at night or morning and with food or without food

Finding Sources
Finding Sources
Searching PubMed

"amlodipine" AND "chronotherapy" AND "evening" AND "morning"

Searching the Web

amlodipine valsartan best time to take morning or night food effect absorption evidence

Reading Web Page

morning versus bedtime valsartan amlodipine blood pressure control results

Searching PubMed

"antihypertensive" AND "bedtime" AND "morning" AND "chronotherapy"

Reading Article
Reading Article
Excellent - very fresh, high-quality evidence. Here's a clear, evidence-based answer:

Morning or Night? With Food or Without?

Short Answer

Evening/bedtime is slightly better, but morning works fine too. The most important rule is consistency - take it at the same time every day. Food does not matter for amlodipine, but valsartan is best taken on an empty stomach or consistently with food.

Timing: Morning vs. Evening

The Evidence

Amlodipine (CCB):
  • Its extremely long half-life (30-50 hours) means it stays in the blood far beyond 24 hours. Because of this, the time of day has minimal impact on its 24-hour BP control. Multiple studies confirm morning or evening dosing give equivalent results for amlodipine alone.
Valsartan (ARB):
  • Has a shorter half-life (6-9 hours). Previous studies suggested bedtime dosing may reduce nocturnal BP slightly more than morning dosing (by about 3 mmHg).
For the Combination (Valsartan + Amlodipine):
A randomized crossover trial (PMC8030911) compared morning vs. bedtime dosing of valsartan/amlodipine 80/5 mg directly and found morning administration was non-inferior to bedtime for nocturnal BP control. Both timings worked equally well.
However, a more recent and larger trial, the OMAN RCT (PMID 40632538, JAMA Network Open, 2025) — 720 patients across 15 hospitals — compared morning vs. bedtime dosing of an ARB/CCB combination (olmesartan/amlodipine) and found:
  • Bedtime dosing reduced nighttime systolic BP by an extra 3.0 mmHg more than morning dosing
  • Better nocturnal BP control rate: 79% vs. 70% (bedtime vs. morning)
  • Improved circadian BP rhythm (dipping pattern)
  • No increased risk of nocturnal hypotension
  • No difference in daytime or 24-hour BP
A 2025 meta-analysis of 56 RCTs (PMID 40251431) confirmed that CCB-based regimens in particular showed the clearest benefit from bedtime chronotherapy.

Bottom Line on Timing

ScenarioRecommendation
General preferenceEvening/bedtime (6-10 PM) — modest but real benefit for nocturnal BP
If side effects at night (dizziness, hypotension)Morning is equally acceptable
Most important ruleSame time every day - consistency beats "perfect" timing
Why nocturnal BP mattersHigh nighttime BP ("non-dipping pattern") is an independent risk factor for stroke and heart attack, often undertreated

Food: Does It Matter?

DrugEffect of FoodRecommendation
AmlodipineNo significant effect on absorptionTake with or without food - your choice
ValsartanFood decreases absorption by ~40% (peak plasma levels reduced)Best taken on an empty stomach (or consistently the same way each day)
Since the combination contains valsartan, ideally take it 30-60 minutes before a meal, or at least 2 hours after eating. If this is inconvenient, pick a consistent approach (always with food, or always without) - consistency matters more than perfection, because valsartan's BP-lowering is dose-adjusted to what you take consistently.
- Goodman & Gilman's Pharmacological Basis of Therapeutics; OMAN RCT (JAMA Network Open 2025); PMC8030911

Practical Recommendation

Take amlodipine/valsartan (Exforge) once daily at bedtime, on an empty stomach (e.g. 9 PM, 2+ hours after dinner). This gives the best nocturnal BP control, takes advantage of amlodipine's peak at 6-12 hours (overnight), and avoids the food interaction with valsartan. If you experience dizziness when standing at night, switch to morning and discuss with your doctor.

If I take 30 minutes before dinner then

Taking it 30 minutes before dinner is actually a reasonable approach - here's why:

30 Minutes Before Dinner

For valsartan: The concern with food is that a large meal reduces valsartan's peak absorption by ~40%. Taking it 30 minutes before means it starts absorbing on an empty stomach, gets a head start, and by the time food arrives the bulk of early absorption has already begun. This is better than taking it mid-meal or right after a heavy meal.
For amlodipine: Food has no effect at all, so timing around meals is irrelevant for this component.

Is It Good Enough?

ScenarioValsartan Absorption
Fasting (2+ hours after eating)Best - full absorption
30 min before a light/moderate mealGood - acceptable in practice
30 min before a heavy/fatty mealModerate - some reduction likely
With or right after a mealLeast optimal

Practical Verdict

Yes, 30 minutes before dinner works well - especially if dinner is a normal-sized meal rather than a very heavy one. Many patients find this easy to remember ("take it when you start preparing dinner") and the consistency of a pre-dinner habit is more valuable long-term than occasionally forgetting a fasting dose.
The only scenario where you'd want to reconsider is if your dinner is consistently very large or high-fat, in which case moving the dose to bedtime (2+ hours after eating) would give more predictable absorption.
Key point: Whatever routine you choose, stick with it every day. Your doctor will adjust your dose based on your BP readings on your consistent routine - switching back and forth between fasting and fed conditions is what actually causes unpredictable BP control.

22 may at night before bed 160/110 ‎23 may at night before meal 175/115 ‎24 may at afternoon 170/110 ‎24 may at night before meal 180/120 ‎

These readings are concerning and need to be addressed clearly.

Your BP Readings

Date & TimeSBPDBPCategory
22 May – night160110Stage 2 / Severe
23 May – before meal175115Stage 2 / Severe
24 May – afternoon170110Stage 2 / Severe
24 May – night (today)180120Hypertensive Urgency

This Is a Hypertensive Urgency

Tonight's reading of 180/120 mmHg meets the threshold for hypertensive urgency (SBP ≥180 and/or DBP ≥120 mmHg).
More importantly, your BP has been trending upward over 3 days despite presumably being on medication. This is not a good sign.

What You Need to Do Right Now

Contact your doctor or go to an emergency department tonight.
Do not wait until tomorrow. The reason urgency needs same-day medical assessment is to check whether there is any organ damage happening silently - this is what separates urgency (no organ damage) from emergency (organ damage in progress).
Your doctor will check for:
  • Headache, visual changes, chest pain, shortness of breath, confusion - these suggest hypertensive emergency, which needs IV treatment in ICU
  • Urine (protein, blood) - kidney involvement
  • ECG - heart strain
  • If none of these are present, it is urgency and can be managed with oral medications

Warning Signs - Go to ER Immediately If You Have Any of These

  • Severe headache or head pounding
  • Blurred vision or seeing spots
  • Chest pain or tightness
  • Shortness of breath
  • Confusion or difficulty speaking
  • Nausea/vomiting
  • Nosebleed that won't stop
  • Weakness or numbness in face/arm/leg

Do NOT

  • Do not take an extra dose of your medication on your own without medical advice
  • Do not lie down and hope it resolves
  • Do not delay if any warning symptoms appear

The bottom line: a BP of 180/120 that has been rising for 3 days requires medical evaluation today. Please contact your doctor or go to the nearest emergency department now.

I haven't start any medication yet for bp

This makes the situation more urgent, not less.

You Are at 180/120 With Zero Medication on Board

This means your BP is reaching hypertensive urgency levels completely untreated. There is no medication causing a temporary spike - this is your baseline state right now.

You Need to Go to the Doctor or ER Tonight

Not tomorrow. Tonight.
At 180/120 with a rising trend over 3 days and no treatment started, the immediate priorities are:
  1. Rule out hypertensive emergency - check if organs are already being damaged
  2. Start medication today - this level of BP cannot wait for a scheduled appointment next week
  3. Find out why - newly discovered hypertension at this level sometimes has a secondary cause (kidney disease, hormonal problem, etc.) that needs to be identified

What the Doctor Will Do

  • Check your symptoms (headache, vision, chest, breathing)
  • Blood tests - kidney function, electrolytes, blood count
  • Urine test - protein or blood in urine signals kidney damage
  • ECG - heart strain from high BP
  • Eye exam possibly - retinal changes from hypertensive damage
  • Start you on antihypertensive medication immediately

While You Wait / On Your Way

  • Sit or lie quietly - avoid exertion
  • No caffeine, no smoking right now
  • Breathe slowly and calmly - anxiety raises BP further
  • If you have any of these symptoms, call emergency services (ambulance) rather than driving yourself:
    • Chest pain
    • Difficulty breathing
    • Sudden severe headache
    • Vision changes
    • Confusion or slurred speech
    • Weakness in face, arm, or leg

The Core Message

180/120 mmHg, untreated, rising over 3 days = go to hospital now.
This is not something to monitor at home and reassess tomorrow. At this BP level, every hour without treatment carries real risk of stroke, heart attack, or kidney damage. Please go tonight.
This is a shared conversation. Sign in to Orris to start your own chat.